A Study to Evaluate Safety and PK Profiles of OLX10010 in Healthy Subjects

Inclusion Criteria: * Males or females, of any race, between 18 and 60 years of age, inclusive, at Screening. * Body mass index (BMI) between 18.0 and 32.0 kg/m2, inclusive, at Screening. * In good health, determined by no clinically significant findings from medical history, physical examination, 12 lead ECG, vital sign measurements, and clinical laboratory evaluations (congenital non haemolytic hyperbilirubinaemia \[eg, Gilbert's syndrome\] is not acceptable) at Screening and/or Check in as assessed by the Investigator (or designee). * Female subjects will be non pregnant and non lactating. * Able to comprehend and willing to sign an ICF and to abide by the study restrictions. Exclusion Criteria: * Male subjects who do not agree, or whose partners of childbearing potential do not agree, to use a male barrier method of contraception (ie, a male condom with spermicide) in addition to a second method of acceptable contraception used by their female partners or to refrain from donating sperm from Check in until 90 days after the Follow up Visit . * Female subjects of childbearing potential who do not agree to use a highly effective method of birth control in conjunction with male barrier method contraception (ie, a male condom with spermicide) or to refrain from donating ova from the time of signing the ICF until 90 days after the Follow up Visit. * Significant history or clinical manifestation of any metabolic, allergic, dermatological, hepatic, renal, haematological, pulmonary, cardiovascular, gastrointestinal, neurological, respiratory, endocrine, or psychiatric disorder, as determined by the Investigator (or designee). * Subjects with serum creatinine \>ULN. * History of significant hypersensitivity, intolerance, or allergy to any drug compound, food, or other substance, unless approved by the Investigator (or designee). * History of alcoholism or drug/chemical abuse within 2 years prior to Check in. * Alcohol consumption of \>28 units per week for males and \>21 units for females. One unit of alcohol equals ½ pint (285 mL) of beer or lager, 1 glass (125 mL) of wine, or 1⁄6 gill (25 mL) of spirits. * Positive alcohol breath test result or positive urine drug screen (confirmed by repeat) at Screening and/or Check in. * Positive hepatitis panel and/or positive human immunodeficiency test at Screening. Subjects whose results are compatible with prior immunisation and not infection may be included at the discretion of the Investigator. * Participation in a clinical study involving administration of an investigational drug (new chemical entity) in the past 3 months (or 5 half lives, whichever is longer) prior to Check in.